Galazka A M, Robertson S E, Oblapenko G P
Global Programme for Vaccines and Immunization, World Health Organization, Geneva, Switzerland.
Eur J Epidemiol. 1995 Feb;11(1):95-105. doi: 10.1007/BF01719954.
Following the introduction of routine immunization with diphtheria toxoid in the 1940s and 1950s, diphtheria incidence declined dramatically in countries of the industrialized world. At the beginning of the 1980s many of these countries were progressing toward elimination of the disease. However, since the mid-1980s there has been a striking resurgence of diphtheria in several countries of Eastern Europe. For 1993, WHO received reports of 15,211 diphtheria cases in Russia and 2,987 cases in Ukraine. The main reasons for the return of diphtheria in these countries were: decreasing immunization coverage among infants and children waning immunity to diphtheria in adults, movements of the population during the last few years, and an irregular supply of vaccines. The outbreak spread to neighboring countries and in 1993 cases were reported in Azerbaijan, Belarus, Estonia, Finland, Kazakhstan, Latvia, Lithuania, Poland, Tajikistan, Turkey, and Uzbekistan. Epidemiological patterns of diphtheria are changing in developing countries, and the disease seems to be following patterns seen in industrialized countries 30 to 40 years ago. In developing countries, routine immunization against diphtheria was introduced in the late 1970s with the Expanded Programme on Immunization. In these countries, coverage of infants with 3 doses of diphtheria toxoid reached 46% in 1985, and 79% in 1992. Recent diphtheria outbreaks in Algeria, China, Ecuator, Jordan, Lesotho and Sudan demonstrate a shift in the age distribution of cases to older children and adults. Rapid clinical and public health responses are required to control diphtheria outbreaks. Three major measures are indicated: high immunization coverage of target groups, prompt diagnosis and management of diphtheria cases, and rapid identification of close contacts with their effective management to prevent secondary cases.
20世纪40年代和50年代引入白喉类毒素常规免疫后,工业化国家的白喉发病率急剧下降。20世纪80年代初,其中许多国家正朝着消除该疾病的方向发展。然而,自20世纪80年代中期以来,东欧几个国家白喉疫情显著反弹。1993年,世卫组织收到报告称,俄罗斯有15211例白喉病例,乌克兰有2987例。这些国家白喉疫情卷土重来的主要原因是:婴幼儿免疫接种覆盖率下降、成人对白喉的免疫力减弱、过去几年的人口流动以及疫苗供应不稳定。疫情蔓延到邻国,1993年阿塞拜疆、白俄罗斯、爱沙尼亚、芬兰、哈萨克斯坦、拉脱维亚、立陶宛、波兰、塔吉克斯坦、土耳其和乌兹别克斯坦均有病例报告。发展中国家白喉的流行病学模式正在发生变化,该病似乎正呈现出30至40年前工业化国家所出现过的模式。在发展中国家,20世纪70年代后期随着扩大免疫规划引入了白喉常规免疫。在这些国家,1985年婴儿3剂白喉类毒素的接种覆盖率达到46%,1992年达到79%。最近在阿尔及利亚、中国、厄瓜多尔、约旦、莱索托和苏丹爆发的白喉疫情表明,病例的年龄分布已转向大龄儿童和成人。需要迅速采取临床和公共卫生应对措施来控制白喉疫情。主要有三项措施:目标群体的高免疫接种覆盖率、白喉病例的及时诊断和管理,以及迅速识别密切接触者并对其进行有效管理以预防二代病例。